{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:06:57Z","timestamp":1791414417385,"version":"4.3.3"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T00:00:00Z","timestamp":1461024000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10067-016-3240-y","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T04:43:21Z","timestamp":1461041001000},"page":"2685-2692","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Calprotectin levels in patients with rheumatoid arthritis to assess and association with exercise treatment"],"prefix":"10.1007","volume":"35","author":[{"given":"Ayse","family":"Acar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banu","family":"Sarifakioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eda Celik","family":"Guzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliye Yildirim","family":"Guzelant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceyda","family":"Karadag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lebriz","family":"Kiziler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"3240_CR1","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","volume":"4","author":"Y Alamanos","year":"2005","unstructured":"Alamanos Y, Drosos AA (2005) Epidemiology of adult rheumatoid arthritis. Autoimmum Rev 4:130\u2013136. doi: 10.1016\/j.autrev.2004.09.002","journal-title":"Autoimmum Rev"},{"key":"3240_CR2","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/rheumatology\/keg281","volume":"42","author":"P Minnock","year":"2003","unstructured":"Minnock P, Fitzgerald O, Bresnihan B (2003) Women with established rheumatoid arthritis perceive pain as the predominant impairment of health status. Rheumatology 42:995\u20131000. doi: 10.1093\/rheumatology\/keg281","journal-title":"Rheumatology"},{"key":"3240_CR3","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1161\/01.CIR.0000099844.31524.05","volume":"108","author":"N Sattar","year":"2003","unstructured":"Sattar N, Mccarey DW, Capell H, Mcinnes IB (2003) Explaining how \u201chigh-grade\u201d systemic inflammation accelerates vascular risk in rheumatoid arthritis. Circulation 108:2957\u20132963. doi: 10.1161\/01.CIR.0000099844.31524.05","journal-title":"Circulation"},{"key":"3240_CR4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/ard.54.8.674","volume":"54","author":"MA Leeuwen Van","year":"1995","unstructured":"Van Leeuwen MA, Westra J, Limburg PC, Van Riel PLCM, Rijswijk MH (1995) Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study. Ann Therheumatic Dis 54:674\u2013677. doi: 10.1136\/ard.54.8.674","journal-title":"Ann Therheumatic Dis"},{"key":"3240_CR5","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1136\/ard.2009.119933","volume":"69","author":"P Emery","year":"2010","unstructured":"Emery P, Deodhar A, Rigby WF, Isaacs JD, Combe B, Racewicz AJ, Latinis K, Abud-Mendoza C, Szczepa\u0144ski LJ, Roschmann RA, Chen A, Armstrong GK, Douglass W, Tyrrell H (2010) Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological na\u00efve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab\u2019s Efficacy in MTX iNadequate rEsponders (SERENE)). Ann Rheum Dis 69:1629\u20131635. doi: 10.1136\/ard.2009.119933","journal-title":"Ann Rheum Dis"},{"key":"3240_CR6","doi-asserted-by":"publisher","first-page":"45478","DOI":"10.1371\/journal.pone.0045478","volume":"7","author":"A Cesaro","year":"2012","unstructured":"Cesaro A, Anceriz N, Plante A, Page N, Tardif MR, Tessier PA (2012) An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. Plos One 7:45478. doi: 10.1371\/journal.pone.0045478","journal-title":"Plos One"},{"key":"3240_CR7","first-page":"2523","volume":"26","author":"P Youssef","year":"1999","unstructured":"Youssef P, Roth J, Frosch M, Costello P, Fitzgerald O, Sorg C, Bresnihan B (1999) Expression of myeloid related proteins (mrp) 8 and 14 and the mrp8\/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 26:2523\u20132528","journal-title":"J Rheumatol"},{"key":"3240_CR8","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P","volume":"42","author":"ME Weinblatt","year":"1999","unstructured":"Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgot SM, Morrell M, Byrne VM, Kaymakcian MV, Strand V (1999) Pharmacokinetics, safety, and efficacy of combination treatment with metotrexate and leflunamide in patients with active rheumatoid arthritis. Arthritis Rheum 42:1322\u20131328. doi: 10.1002\/1529-0131(199907)42:7<1322::AID-ANR4>3.0.CO;2-P","journal-title":"Arthritis Rheum"},{"key":"3240_CR9","doi-asserted-by":"publisher","unstructured":"Malemud CJ (2011) Myeloid-related protein activity in rheumatoid arthritis. Sage-Hindawi Access to Research \u0130nternational journal of Inflammation Article ID 580295. Doi: 10.4061\/2011\/580295","DOI":"10.4061\/2011\/580295"},{"issue":"4","key":"3240_CR10","first-page":"445","volume":"18","author":"H Nakamura","year":"2000","unstructured":"Nakamura H, Ueki Y, Sakito S, Matsumoto K, Yano M, Miyake S, Tominaga Y, Eguchi K (2000) Clinical effects of actarit in rheumatoid arthritis: improvement of early disease activity mediated by reduction of serum concentrations of nitric oxide. Clin Exp Rheumatol 18(4):445\u2013450","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"3240_CR11","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1249\/mss.0b013e31811ece1c","volume":"39","author":"LK Stewart","year":"2007","unstructured":"Stewart LK, Flynn MG, Campbell WW, Craig BA, Robinson JP, Timmerman KL, Mcfarlin BK, Coen PM, Talbert E (2007) The influence exercise training on inflammatory cytokines and C-reactive protein. Med Sci Sports Exerc 39(10):1714\u20131719. doi: 10.1249\/mss.0b013e31811ece1c","journal-title":"Med Sci Sports Exerc"},{"key":"3240_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1590\/S0482-50042011000500008","volume":"51","author":"B Gualano","year":"2011","unstructured":"Gualano B, Pinto AL, Perondi BM, Roschel H, Sallum AM, Hayashi AP, Solis MY, Silva CA (2011) Therapeutic effects of exercise training in patients with pediatric rheumatic diseases. Rev Bras Reumatol 51:490\u2013496. doi: 10.1590\/S0482-50042011000500008","journal-title":"Rev Bras Reumatol"},{"issue":"9","key":"3240_CR13","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27580","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman A et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. doi: 10.1002\/art.27580","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3240_CR14","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/rheumatology\/keq406","volume":"50","author":"P Kiely","year":"2011","unstructured":"Kiely P, Walsh D, Williams R, Young A, Early Rheumatoid Arthritis Network (2011) Outcome in rheumatoid arthritis patients with continued conventional therapy for moderate disease activity\u2014the early RA network (ERAN). Rheumatology (Oxford) 50(5):926\u2013931. doi: 10.1093\/rheumatology\/keq406","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3240_CR15","doi-asserted-by":"publisher","first-page":"r178","DOI":"10.1186\/ar3503","volume":"13","author":"HB Hammer","year":"2011","unstructured":"Hammer HB, Fagerhol MK, Wien TN, Kvien TK (2011) The soluble biomarker calprotectin (an s100 protein) is associated to ultrasonographic synovitis scoresand is sensitive to change in patients with rheumatoid arthritis treated with a dalimumab. Arthritis Res Ther 13(5):r178. doi: 10.1186\/ar3503","journal-title":"Arthritis Res Ther"},{"key":"3240_CR16","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.4049\/jimmunol.160.3.1427","volume":"160","author":"RA Newton","year":"1998","unstructured":"Newton RA, Hogg N (1998) The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils. J Immunol 160:1427\u20131435","journal-title":"J Immunol"},{"issue":"3","key":"3240_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","volume":"43","author":"M Frosch","year":"2000","unstructured":"Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderk\u00f6tter C, Harms E, Sorg C, Roth J (2000) Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 43(3):628\u2013637. doi: 10.1002\/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X","journal-title":"Arthritis Rheum"},{"key":"3240_CR18","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1002\/art.11079","volume":"48","author":"C Ryckman","year":"2003","unstructured":"Ryckman C, McColl SR, Vandal K, de M\u00e9dicis R, Lussier A, Poubelle PE, Tessier PA (2003) Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis. Arthritis Rheum 48:2310\u20132320. doi: 10.1002\/art.11079","journal-title":"Arthritis Rheum"},{"key":"3240_CR19","doi-asserted-by":"publisher","first-page":"3762","DOI":"10.1002\/art.20631","volume":"50","author":"D Foell","year":"2004","unstructured":"Foell D, Roth J (2004) Proinflammatory s100 proteins in arthritis and auto-immune disease. Arthritis Rheum 50:3762\u20133771. doi: 10.1002\/art.20631","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3240_CR20","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1136\/ard.2006.064741","volume":"66","author":"HB Hammer","year":"2007","unstructured":"Hammer HB, Odegard S, Fagerhol MK, Landew\u00e9 R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK (2007) Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 66(8):1093\u20131097. doi: 10.1136\/ard.2006.064741","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3240_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.11648\/j.iji.20140201.12","volume":"2","author":"N Adel","year":"2014","unstructured":"Adel N, William M, Swaff RA, Hassan S (2014) Serum calprotectin level for diagnosis and detection of disease activity in rheumatoid arthritis. Int J Immunol 2(1):6\u201310. doi: 10.11648\/j.iji.20140201.12","journal-title":"Int J Immunol"},{"issue":"2","key":"3240_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3109\/03009749109165280","volume":"20","author":"HB Berntzen","year":"1991","unstructured":"Berntzen HB, Olmez U, Fagerhol MK, Munthe E (1991) The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 20(2):74\u201382. doi: 10.3109\/03009749109165280","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"3240_CR23","first-page":"733","volume":"21","author":"JG Brun","year":"1994","unstructured":"Brun JG, Jonsson R, Haga HJ (1994) Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 21(4):733\u2013738","journal-title":"J Rheumatol"},{"issue":"1","key":"3240_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s40291-013-0016-9","volume":"17","author":"M Garc\u00eda-Arias","year":"2013","unstructured":"Garc\u00eda-Arias M, Pascual-Salcedo D, Ramiro S, Ueberschlag ME, Jermann TM, Cara C, Mart\u00edn-Mola E, Balsa A (2013) Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther 17(1):49\u201356. doi: 10.1007\/s40291-013-0016-9","journal-title":"Mol Diagn Ther"},{"issue":"3","key":"3240_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/annrheumdis-2013-203923","volume":"74","author":"IY Choi","year":"2015","unstructured":"Choi IY, Gerlag DM, Herenius MJ, Thurlings RM, Wijbrandts CA, Foell D, Vogl T, Roth J, Tak PP, Holzinger D (2015) MRP8\/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis 74(3):499\u2013505. doi: 10.1136\/annrheumdis-2013-203923","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"3240_CR26","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/rheumatology\/kep452","volume":"49","author":"A Baillet","year":"2010","unstructured":"Baillet A, Trocm\u00e9 C, Berthier S, Arlotto M, Grange L, Chenau J, Qu\u00e9tant S, S\u00e8ve M, Berger F, Juvin R, Morel F, Gaudin P (2010) Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) 49(4):671\u2013682. doi: 10.1093\/rheumatology\/kep452","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3240_CR27","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","volume":"51","author":"AJ Farrell","year":"1992","unstructured":"Farrell AJ, Blake DR, Palmer RM, Moncada S (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 51(11):1219\u20131222","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3240_CR28","first-page":"230","volume":"23","author":"Y Ueki","year":"1996","unstructured":"Ueki Y, Miyake S, Tominaga Y, Eguchi K (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J Rheumatol 23(2):230\u2013236","journal-title":"J Rheumatol"},{"issue":"6","key":"3240_CR29","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","volume":"71","author":"D Holzinger","year":"2012","unstructured":"Holzinger D, Frosch M, Kastrup A, Prince FH, Otten MH, Van Suijlekom-Smit LW, ten Cate R, Hoppenreijs EP, Hansmann S, Moncrieffe H, Ursu S, Wedderburn LR, Roth J, Foell D, Wittkowski H (2012) The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis. Ann Rheum Dis 71(6):974\u2013980. doi: 10.1136\/annrheumdis-2011-200598","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"3240_CR30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1002\/art.1780360803","volume":"36","author":"M Stefanovic-Racic","year":"1993","unstructured":"Stefanovic-Racic M, Stadler J, Evans CH (1993) Nitric oxide and arthritis. Arthritis Rheum 36(8):1036\u20131044. doi: 10.1002\/art.1780360803","journal-title":"Arthritis Rheum"},{"key":"3240_CR31","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/ard.2007.069690","volume":"67","author":"G Wells","year":"2008","unstructured":"Wells G, Li T, Maxwell L, Maclean R, Tugwell P (2008) Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis. Ann Rheum Dis 67:260\u2013265","journal-title":"Ann Rheum Dis"},{"key":"3240_CR32","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.2.5544.85","volume":"2","author":"LE B\u00f6ttiger","year":"1967","unstructured":"B\u00f6ttiger LE, Svedberg CA (1967) Normal erythrocyte sedimentation rate and age. Br Med J 2:85\u201387","journal-title":"Br Med J"},{"key":"3240_CR33","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780340819","volume":"34","author":"I Kushner","year":"1991","unstructured":"Kushner I (1991) C-reactive protein in rheumatology. Arthritis Rheum 34:1065\u20131068","journal-title":"Arthritis Rheum"},{"key":"3240_CR34","unstructured":"Pincus T, Braun J, Kavanaugh A, Smolen JS (2014) Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care. Clin Exp Rheumatol 32: S\u20131"},{"issue":"4","key":"3240_CR35","doi-asserted-by":"publisher","first-page":"R122","DOI":"10.1186\/ar3426","volume":"13","author":"L Andr\u00e9s Cerezo","year":"2011","unstructured":"Andr\u00e9s Cerezo L, Mann H, Pecha O, Ple\u0161tilov\u00e1 L, Pavelka K, Vencovsk\u00fd J, Senolt L (2011) Decreases in serum levels of S100A8\/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 13(4):R122. doi: 10.1186\/ar3426","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"3240_CR36","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/rheumatology\/kem260","volume":"47","author":"GS Metsios","year":"2008","unstructured":"Metsios GS, Stavropoulos-Kalinoglou (2008) Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 47(3):239\u2013248. doi: 10.1093\/rheumatology\/kem260","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"3240_CR37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0003-9993(94)90003-5","volume":"75","author":"KK Lyngberg","year":"1994","unstructured":"Lyngberg KK, Harreby M, Bentzen H, Frost B, Danneskiold-Sams\u00f8e B (1994) Elderly rheumatoid arthritis patients on steroid treatment tolerate physical training without an increase in disease activity. Arch Phys Med Rehabil 75(11):1189\u20131195","journal-title":"Arch Phys Med Rehabil"},{"issue":"7","key":"3240_CR38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00421-014-2877-y","volume":"114","author":"AJ Wadley","year":"2014","unstructured":"Wadley AJ, Veldhuijzen van Zanten JJ, Stavropoulos-Kalinoglou A, Metsios GS, Smith JP, Kitas GD, Aldred S (2014) Three months of moderate-intensity exercise reduced plasma 3-nitrotyrosine in rheumatoid arthritis patients. Eur J Appl Physiol 114(7):1483\u20131492. doi: 10.1007\/s00421-014-2877-y","journal-title":"Eur J Appl Physiol"},{"issue":"10","key":"3240_CR39","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/01.ATV.0000140199.14930.32","volume":"24","author":"K Okita","year":"2004","unstructured":"Okita K, Nishijima H, Murakami T, Nagai T, Morita N, Yonezawa K, Iizuka K, Kawaguchi H, Kitabatake A (2004) Can exercise training with weight loss lower serum C-reactive protein levels? Arterioscler Thromb Vasc Biol 24(10):1868\u20131873. doi: 10.1161\/01.ATV.0000140199.14930.32","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"3240_CR40","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.metabol.2006.06.021","volume":"55","author":"GA Kelley","year":"2006","unstructured":"Kelley GA, Kelley KS (2006) Effects of aerobic exercise on C-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 55(11):1500\u20131507. doi: 10.1016\/j.metabol.2006.06.021","journal-title":"Metabolism"},{"issue":"6","key":"3240_CR41","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/BOR.0b013e3283319d53","volume":"21","author":"GA Nader","year":"2009","unstructured":"Nader GA, Lundberg IE (2009) Exercise as an anti-inflammatory intervention to combat inflammatory diseases of muscle. Curr Opin Rheumatol 21(6):599\u2013603. doi: 10.1097\/BOR.0b013e3283319d53","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"3240_CR42","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1136\/thx.2006.069310","volume":"62","author":"I Vogiatzis","year":"2007","unstructured":"Vogiatzis I, Stratakos G, Simoes DC, Terzis G, Georgiadou O, Roussos C, Zakynthinos S (2007) Effects of rehabilitative exercise on peripheral muscle TNFalpha, IL-6, IGF-I and MyoD expression in patients with COPD. Thorax 62(11):950\u2013956. doi: 10.1136\/thx.2006.069310","journal-title":"Thorax"},{"issue":"4","key":"3240_CR43","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ehj.2003.12.006","volume":"25","author":"M Tr\u00f8seid","year":"2004","unstructured":"Tr\u00f8seid M, Lappeg\u00e5rd KT, Claudi T, Dam\u00e5s JK, M\u00f8rkrid L, Brendberg R, Mollnes TE (2004) Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome. Eur Heart J 25(4):349\u2013355. doi: 10.1016\/j.ehj.2003.12.006","journal-title":"Eur Heart J"},{"issue":"9","key":"3240_CR44","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1053\/euhj.2000.2285","volume":"22","author":"S Adamopoulos","year":"2001","unstructured":"Adamopoulos S, Parissis J, Kroupis C, Georgiadis M, Karatzas D, Karavolias G, Koniavitou K, Coats AJ, Kremastinos DT (2001) Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 22(9):791\u2013797. doi: 10.1053\/euhj.2000.2285","journal-title":"Eur Heart J"},{"issue":"2","key":"3240_CR45","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1096\/fj.00-0274com","volume":"15","author":"JS Greiwe","year":"2001","unstructured":"Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF (2001) Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 15(2):475\u2013482. doi: 10.1096\/fj.00-0274com","journal-title":"FASEB J"},{"issue":"3","key":"3240_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/(SICI)1098-240X(199706)20:3<195::AID-NUR3>3.0.CO;2-D","volume":"20","author":"GB Neuberger","year":"1997","unstructured":"Neuberger GB, Press AN, Lindsley HB, Hinton R, Cagle PE, Carlson K, Scott S, Dahl J, Kramer B (1997) Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nurs Health 20(3):195\u2013204. doi: 10.1002\/(SICI)1098-240X(199706)20:3<195::AID-NUR3>3.0.CO;2-D","journal-title":"Res Nurs Health"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3240-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-016-3240-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3240-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-016-3240-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T20:58:25Z","timestamp":1718485105000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-016-3240-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3240"],"URL":"https:\/\/doi.org\/10.1007\/s10067-016-3240-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]}}}